Improvement in screening for colorectal cancer associated with the use of immunochemical faecal occult blood test

被引:0
|
作者
Launoy, G. [1 ]
机构
[1] CHU Caen, UFR Med, INSERM, UCBN,EA 3936,ERI 3, F-14000 Caen, France
来源
PATHOLOGIE BIOLOGIE | 2009年 / 57卷 / 06期
关键词
Colorectal cancer; Colorectal adenoma; Screening; Immunochemical; Guaiac; Sensitivity; Specificity; Acceptability; RANDOMIZED CONTROLLED-TRIAL; POPULATION; MORTALITY; RISK; PARTICIPATION; SENSITIVITY; REDUCTION; DISTRICT;
D O I
10.1016/j.patbio.2008.07.010
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
Faecal occult blood tests (FOBT) have been established as the most relevant procedure for colorectal cancer screening in the general average risk population. Immunochemical FOBT consists in monoclonal antibodies reacting with the globin of the haemoglobin. These tests provide higher performances than traditional guaiac tests. They do not need any diet restriction and their analytic sensitivity is higher. An increasing number of papers suggest that their acceptance and clinical performances in the general population are more satisfactory than the guaiac test. The use of automated reading allowed to cut the process price making it similar to the guaiac test. The providing of quantitative measure of haemoglobin allows to choose the positivity threshold associated with the best balance between sensitivity, specificity and positivity rate. Comparative studies conducted in France suggest the use of a positivity threshold allowing an increase in both sensitivity and specificity compared to the guaiac tests. (C) 2008 Elsevier Masson SAS. Tous droits reserves.
引用
收藏
页码:488 / 492
页数:5
相关论文
共 50 条
  • [31] Performance characteristics of faecal occult blood tests: Which test to use for colorectal cancer screening?
    Oort, Frank
    Droste, Jochim Terhaarsive
    Craanen, Mike
    van der Hulst, Rene
    van Heukelem, Henk
    Loffeld, Ruud
    Wesdorp, Eric
    van Wanrooy, Roy
    de Baay, Laura
    Mutsaers, Liesbeth
    van de Reijt, Suzanne
    Meijer, Gerrit
    Mulder, Chris
    CELLULAR ONCOLOGY, 2008, 30 (02) : 159 - 159
  • [32] Performance characteristics of faecal occult blood tests: Which test to use for colorectal cancer screening
    Oort, F.
    Droste, J. S. Terhaar Sive
    Craanen, M. E.
    van Wanrooy, R. L. J.
    de Baay, L.
    Mutsaers, E. M.
    van de Reijt, S.
    Mulder, C. J. J.
    van der Hulst, R. W. M.
    van Heukelem, H. A.
    Loffeld, R. J. L. F.
    Wesdorp, I. C. E.
    Meijers, G. A.
    ANNALS OF ONCOLOGY, 2008, 19 : I10 - I11
  • [33] Performance characteristics of faecal occult blood tests: Which test to use for colorectal cancer screening?
    Terhaar Sive Droste, Jochim S.
    Craanen, Michael E.
    Van der Hulst, Rene W.
    Snel, Pleun
    Depla, Annekatrien
    Loffeld, Ruud J.
    De Baaij, Laura
    Mutsaers, Liesbeth
    Van Wanrooy, Roy
    Van der Reijt, Suzanne
    Mulder, Chris J.
    GASTROENTEROLOGY, 2007, 132 (04) : A316 - A316
  • [34] Performance characteristics of faecal occult blood tests: Which test to use for colorectal cancer screening?
    Oort, E. A.
    sive Droste, J. S. Terhaar
    Craanen, M. E.
    van der Hulst, R. W. M.
    van Heukelem, H. A.
    Loffeld, R. J. L. E.
    Wesdorp, I. C. E.
    van Wanrooy, R. L. J.
    de Baay, L.
    Mutsaers, E. M.
    van der Reijt, S.
    Mulder, C. J. J.
    SAMJ SOUTH AFRICAN MEDICAL JOURNAL, 2007, 97 (08): : 614 - 614
  • [35] A sensitive guaiac faecal occult blood test is less useful than an immunochemical test for colorectal cancer screening in a Chinese population
    Wong, BCY
    Wong, WM
    Cheung, KL
    Tong, TSM
    Rozen, P
    Young, GP
    Chu, KW
    Ho, J
    Law, WL
    Tung, HM
    Lai, KC
    Hu, WHC
    Chan, CK
    Lam, SK
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2003, 18 (09) : 941 - 946
  • [36] Faecal immunochemical test outside colorectal cancer screening?
    Pin-Vieito, Noel
    Puga, Manuel
    Fernandez-de-Castro, Daniel
    Cubiella, Joaquin
    WORLD JOURNAL OF GASTROENTEROLOGY, 2021, 27 (38) : 6415 - 6429
  • [37] Faecal immunochemical test outside colorectal cancer screening?
    Noel Pin-Vieito
    Manuel Puga
    Daniel Fernández-de-Castro
    Joaquín Cubiella
    World Journal of Gastroenterology, 2021, (38) : 6415 - 6429
  • [38] A comparison of the acceptance of immunochemical faecal occult blood test and colonoscopy in colorectal cancer screening: a prospective study among Chinese
    Wong, M. C. S.
    Tsoi, K. K. F.
    Ng, S. S. M.
    Lou, V. W. Q.
    Choi, S. Y. P.
    Ling, K. W. K.
    Chan, F. K. L.
    Griffiths, S. M.
    Sung, J. J. Y.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2010, 32 (01) : 74 - 82
  • [39] Attitudes towards the Faecal Occult Blood Test (FOBT) versus the Faecal Immunochemical Test (FIT) for colorectal cancer screening: perceived ease of completion and disgust
    Julie A. Chambers
    Alana S. Callander
    Rebecca Grangeret
    Ronan E. O’Carroll
    BMC Cancer, 16
  • [40] Colorectal cancer screening: Why immunochemical faecal occult blood test performs as well with either one or two samples
    Guittet, Lydia
    Bouvier, Veronique
    Guillaume, Elodie
    Levillain, Romuald
    Ruiz, Angela
    Lantieri, Olivier
    Launoy, Guy
    DIGESTIVE AND LIVER DISEASE, 2012, 44 (08) : 694 - 699